Christopher Benoit
Christopher Benoit has been appointed as CEO of TwinStrand Biosciences after joining the company's board of directors earlier this year. Previously, he held various roles at Enzymatics, a company he co-founded. Qiagen acquired Enzymatis in 2014. He is also a member of the board of TangenDX, a point-of-care molecular diagnostics company.